A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Rain Therapeutics, Inc.
Start Date
January 13, 2022
End Date
June 30, 2026
Administered By
Duke Cancer Institute
Awarded By
Rain Therapeutics, Inc.
Start Date
January 13, 2022
End Date
June 30, 2026